Femasys inc.FEMY.US Overview
FEMY Overall Performance
FEMY AI Analysis & Strategy
FEMY Recent Performance
-0.49%
Femasys inc.
0.81%
Avg of Sector
-1.14%
S&P500
FEMY PowerScanner
FEMY Key Information
FEMY Valuation Metrics
FEMY Earnings Table
FEMY Profile
Femasys Inc., a biomedical company, focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a biopsy device for endocervical curettage; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. It also commercializes FemVue saline-air device in the United States, Europe, Canada, Japan, and internationally. The company offers its infertility products to obstetrics-gynecological physicians, related healthcare professionals, women's healthcare provider organizations, and reproductive endocrinologists. In addition, it provides non-surgical product technologies. Femasys Inc. was incorporated in 2004 and is based in Suwanee, Georgia.